Page last updated: 2024-08-24

capecitabine and Leukemia, Lymphocytic, Chronic, T Cell

capecitabine has been researched along with Leukemia, Lymphocytic, Chronic, T Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dessart, P; Le Dû, K; Lemaire, P; Maillard, H; Prophette, B; Sandrini, J	1

Reviews

1 review(s) available for capecitabine and Leukemia, Lymphocytic, Chronic, T Cell

Article	Year
[T-cell prolymphocytic leukemia: potential diagnostic pitfalls]. Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:12 Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Chromosome Deletion; Combined Modality Therapy; Delayed Diagnosis; Diagnostic Errors; Fatal Outcome; Humans; Immunophenotyping; Leukemia, Prolymphocytic, T-Cell; Male; Neoplasms, Second Primary; Pentostatin; Rectal Neoplasms; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes	2014

Article

Year

[T-cell prolymphocytic leukemia: potential diagnostic pitfalls].

Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:12

Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Chromosome Deletion; Combined Modality Therapy; Delayed Diagnosis; Diagnostic Errors; Fatal Outcome; Humans; Immunophenotyping; Leukemia, Prolymphocytic, T-Cell; Male; Neoplasms, Second Primary; Pentostatin; Rectal Neoplasms; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes

2014